These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12865415)

  • 1. Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy.
    Jumbe N; Louie A; Leary R; Liu W; Deziel MR; Tam VH; Bachhawat R; Freeman C; Kahn JB; Bush K; Dudley MN; Miller MH; Drusano GL
    J Clin Invest; 2003 Jul; 112(2):275-85. PubMed ID: 12865415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ; Smith-Moland E; Goering RV; Hanson ND; Lister PD
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):43-50. PubMed ID: 15380277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.
    Lister PD; Wolter DJ; Wickman PA; Reisbig MD
    J Antimicrob Chemother; 2006 May; 57(5):999-1003. PubMed ID: 16513915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.
    Maciá MD; Borrell N; Segura M; Gómez C; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):975-83. PubMed ID: 16495260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic efflux, a mechanism of multiple resistance in Pseudomonas aeruginosa].
    Pechère JC; Michéa-Hamzhepour M; Köhler T
    Bull Acad Natl Med; 1998; 182(3):599-612; discussion 613-5. PubMed ID: 9673055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
    Plasencia V; Borrell N; Maciá MD; Moya B; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2574-81. PubMed ID: 17470655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
    Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
    J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crisis of resistance: identifying drug exposures to suppress amplification of resistant mutant subpopulations.
    Drusano GL; Louie A; Deziel M; Gumbo T
    Clin Infect Dis; 2006 Feb; 42(4):525-32. PubMed ID: 16421797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.
    Paladino JA; Sunderlin JL; Forrest A; Schentag JJ
    J Antimicrob Chemother; 2003 Sep; 52(3):457-63. PubMed ID: 12888598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.
    Dupont P; Hocquet D; Jeannot K; Chavanet P; Plésiat P
    J Antimicrob Chemother; 2005 Apr; 55(4):518-22. PubMed ID: 15722391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial-population responses to drug-selective pressure: examination of garenoxacin's effect on Pseudomonas aeruginosa.
    Tam VH; Louie A; Deziel MR; Liu W; Leary R; Drusano GL
    J Infect Dis; 2005 Aug; 192(3):420-8. PubMed ID: 15995955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
    Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
    Rubin J; Walker RD; Blickenstaff K; Bodeis-Jones S; Zhao S
    Vet Microbiol; 2008 Sep; 131(1-2):164-72. PubMed ID: 18395369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical modelling response of Pseudomonas aeruginosa to meropenem.
    Tam VH; Schilling AN; Poole K; Nikolaou M
    J Antimicrob Chemother; 2007 Dec; 60(6):1302-9. PubMed ID: 17913722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ; Black JA; Lister PD; Hanson ND
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing.
    Tam VH; Ledesma KR; Schilling AN; Lim TP; Yuan Z; Ghose R; Lewis RE
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):427-33. PubMed ID: 19631096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
    Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa.
    Mesaros N; Glupczynski Y; Avrain L; Caceres NE; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2007 Mar; 59(3):378-86. PubMed ID: 17289770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E; Löfmark S; Wretlind B; Andersson DI
    J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.